The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...

In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).

A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can minimize flare risk and support the successful discontinuation of GCs in ...

Over 55,000 Georgians are living with lupus. Whether you are living with lupus or loving someone with lupus, we are here. All registration pages are open for this year's walk season! Sign up today, ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

Explore our lupus resources in English, Spanish, and Chinese. The Lupus Foundation of America, as Secretariat of the World Lupus Federation (WLF), provides various resources for WLF member ...

Exagen Inc. has announced conditional approval from the New York State Department of Health for its innovative new biomarker assays designed to improve the detection of systemic lupus erythematosus ...

Nyobie’s journey with lupus is a story of resilience, empowerment, and the transformative strength of finding her voice. Diagnosed in 2010 after a difficult 19-year journey through eight different ...

This episode of The Expert Series explores the complex relationship between lupus and fibromyalgia, focusing on definitions, symptoms, overlapping conditions, treatment approaches, mental health ...

An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of B-cell mediated autoimmune diseases, including systemic lupus erythematosus ...